# A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy

> **NCT02045160** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Pneumocystis Jirovecii Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02045160
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02045160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02045160, "A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02045160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
